Market News — Saturday, September 26, 2026
News highlights with AI-explained potential impact from our daily market analysis.
VEON launches a large buyback tied to a major shareholder sale
The company approved repurchasing 72.5 million shares, and one holder owning about 45.46% agreed to sell 32.96 million shares back through the buyback process.
Potential Impact: This could reduce shares outstanding and support per-share value, but investors should watch execution, cancellation approval, and whether the business can fund the repurchase comfortably.
Apple loses a major patent case
A federal jury ordered Apple to pay over $5.7 billion for patent infringement related to vibration technology in iPhones and Apple Watches.
Potential Impact: This is a reminder that even world-class businesses can face large legal bills and distraction when intellectual property disputes go against them.
Prime Medicine clears an important regulatory hurdle
The FDA cleared its investigational new drug application for PM647, allowing the company to move into clinical trials for Alpha-1 Antitrypsin Deficiency.
Potential Impact: For biotech investors, this is meaningful because it moves the program from promise to testing, which can improve the investment case if development continues to progress.
TrueBlue is tied to high-growth infrastructure demand
The company is being described as a beneficiary of energy infrastructure and data center buildouts, with forward EBITDA growth of 73% and 12% revenue growth in 2Q26.
Potential Impact: If those trends continue, earnings power could rise meaningfully, but investors should remain aware that a strong share price run can leave less room for error.
Dollar General expands same-day delivery through Instacart
Dollar General is starting with 7,000 stores and plans to expand same-day delivery to 20,000 locations.
Potential Impact: This could improve convenience and broaden the company’s digital reach, but it also brings execution risks around inventory, staffing, and costs.
A big IPO filing arrives, but the market tone is still cautious
The Fidelis Partnership filed for a U.S. IPO, backed by Blackstone, with first-half net income of $127.5 million and revenue of $407.5 million.
Potential Impact: This suggests there is still appetite for public listings, but the article also notes the broader IPO market has had a tepid start because of surging bond yields and tighter rates.